ROIVRoivant SciencesHealth Care
$34.71EarningsNov 9, 2026
1D—1W—1M—3M—1Y—
Market cap$28.2BCompany infoRevenue$8.3M52-wk range$12 – $38IndustryBiotechnologyWebsiteroivant.comRelated—
Yahoo
EDGAR
CNN
FinvizMarket Beat
Perform
n/a
1 Year
n/a1 Month
n/a1 Week
n/a1 Day
Rank Durability
Persist
n/a
1 Year
n/a6 Month
n/a3 Month
n/aTrend Hold
Business Beat
Profit
n/a
Composite
n/aRevenue
n/aMargin
n/aCash Flow
Money Flow
Pressure
n/a
60 Day
n/a30 Day
n/a5 Day
n/a2 Day
▲ +193.9% · 1YSPY
Weekly rank vs S&P 500 · 52wk
Not enough history to plot
ValuationHow the price is priced — vs cohort and vs its own past
MetricValueUnivSect5-yr range
P / E———
P / S3413.4×00
121
2724
P / FCF———
EV / EBITDA———
P / E (fwd)———
ProfitabilityMargins and returns on capital
MetricValueUnivSect5-yr range
Gross margin84.4%9689
68%
97%
Operating margin-15560.6%01
-15561%
8098%
Net margin-3629.2%01
-6080%
8445%
ROE-6.8%716
-103%
127%
ROIC-22.4%27
-57%
81%
Financial healthLeverage and liquidity
MetricValueUnivSect5-yr range
Debt / equity0.009385
0.0
0.5
Net debt / EBITDA———
Current ratio18.379899
Interest coverage999.0×9695
Per shareTTM, with year-over-year change
Revenue / share$0.01▼ −72%
EPS (diluted)$-0.51▼ −104%
FCF / share$-0.93▲ +10%
Est. EPS growth (fwd)—